Suppr超能文献

PAK1与NF2/墨林的拮抗作用驱动少突胶质细胞中髓鞘膜的扩张。

Antagonistic actions of PAK1 and NF2/Merlin drive myelin membrane expansion in oligodendrocytes.

作者信息

Baudouin Lucas, Adès Noémie, Kanté Kadia, Bachelin Corinne, Hmidan Hatem, Deboux Cyrille, Panic Radmila, Ben Messaoud Rémy, Velut Yoan, Hamada Soumia, Pionneau Cédric, Duarte Kévin, Poëa-Guyon Sandrine, Barnier Jean-Vianney, Nait Oumesmar Brahim, Bouslama-Oueghlani Lamia

机构信息

Sorbonne Université, Institut du Cerveau, Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié-Salpêtrière, Paris, France.

Al-Quds University, Faculty of Medicine, Jerusalem, Palestine.

出版信息

Glia. 2024 Aug;72(8):1518-1540. doi: 10.1002/glia.24570. Epub 2024 May 25.

Abstract

In the central nervous system, the formation of myelin by oligodendrocytes (OLs) relies on the switch from the polymerization of the actin cytoskeleton to its depolymerization. The molecular mechanisms that trigger this switch have yet to be elucidated. Here, we identified P21-activated kinase 1 (PAK1) as a major regulator of actin depolymerization in OLs. Our results demonstrate that PAK1 accumulates in OLs in a kinase-inhibited form, triggering actin disassembly and, consequently, myelin membrane expansion. Remarkably, proteomic analysis of PAK1 binding partners enabled the identification of NF2/Merlin as its endogenous inhibitor. Our findings indicate that Nf2 knockdown in OLs results in PAK1 activation, actin polymerization, and a reduction in OL myelin membrane expansion. This effect is rescued by treatment with a PAK1 inhibitor. We also provide evidence that the specific Pak1 loss-of-function in oligodendroglia stimulates the thickening of myelin sheaths in vivo. Overall, our data indicate that the antagonistic actions of PAK1 and NF2/Merlin on the actin cytoskeleton of the OLs are critical for proper myelin formation. These findings have broad mechanistic and therapeutic implications in demyelinating diseases and neurodevelopmental disorders.

摘要

在中枢神经系统中,少突胶质细胞(OLs)形成髓鞘依赖于肌动蛋白细胞骨架从聚合状态向解聚状态的转变。触发这种转变的分子机制尚待阐明。在此,我们确定p21激活激酶1(PAK1)是OLs中肌动蛋白解聚的主要调节因子。我们的结果表明,PAK1以激酶抑制形式在OLs中积累,触发肌动蛋白解聚,进而导致髓鞘膜扩张。值得注意的是,对PAK1结合伙伴的蛋白质组学分析确定NF2/梅林是其内源性抑制剂。我们的研究结果表明,OLs中Nf2基因敲低会导致PAK1激活、肌动蛋白聚合以及OL髓鞘膜扩张减少。用PAK1抑制剂治疗可挽救这种效应。我们还提供证据表明,少突胶质细胞中特异性的Pak1功能丧失会在体内刺激髓鞘增厚。总体而言,我们的数据表明,PAK1和NF2/梅林对OLs肌动蛋白细胞骨架的拮抗作用对于正常髓鞘形成至关重要。这些发现对脱髓鞘疾病和神经发育障碍具有广泛的机制和治疗意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验